Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Hypersensitivity Reaction

Free Subscription Articles published in Pediatr Dermatol Retrieve available abstracts of 86 articles: HTML format

Single Articles

June 2026
1. SCHNEIDERMAN M, Derrick KM
   Childhood Atopic Dermatitis and Performance on Standardized Testing: A U.S. Birth Cohort Study.
   Pediatr Dermatol. 2026 Jun 14. doi: 10.1111/pde.70266.
   PubMed     Abstract available
   
   
   
2. CHOKSHI A, Keelin J, Foy V, Choudhury S, et al
   Topical Janus Kinase Inhibitors for Pediatric Atopic Dermatitis: A Systematic Review of Efficacy and Safety.
   Pediatr Dermatol. 2026 Jun 14. doi: 10.1111/pde.70298.
   PubMed     Abstract available
   
   
   May 2026
3. BUETHE MG, Sy T, Eichenfield LF
   Safety of Dupilumab and Risk of Cutaneous T-Cell Lymphoma in Pediatric Patients With Atopic Dermatitis: A Data-Driven Guide to Counseling Patients and Families.
   Pediatr Dermatol. 2026 May 31. doi: 10.1111/pde.70285.
   PubMed     Abstract available
   
   
   
4. MCDOWELL M, Navarro A, Siddiqui O, Hanna C, et al
   Therapeutic Patient Education for Pediatric Atopic Dermatitis Patients: A Randomized Controlled Trial.
   Pediatr Dermatol. 2026 May 19. doi: 10.1111/pde.70248.
   PubMed     Abstract available
   
   
   
5. THEODOSIOU G, Svensson A
   Dupilumab-Induced Psoriasis in an Adolescent With Severe Atopic Dermatitis: Successful Management With Abrocitinib.
   Pediatr Dermatol. 2026 May 18. doi: 10.1111/pde.70269.
   PubMed     Abstract available
   
   
   
6. OBIJIOFOR CE, Martinez M, Chappidi R, Friedman S, et al
   Integrating Patient-Reported Outcome Measures in Atopic Dermatitis Clinical Practice: An Analysis of the Patient-Oriented Eczema Measure.
   Pediatr Dermatol. 2026 May 4. doi: 10.1111/pde.70231.
   PubMed     Abstract available
   
   
   
7. ZEMLOK SK, Schwartz J, Sandler M, Woodard E, et al
   Beyond the Grid: A Case Series of Parent-Child Comprehension of Patch Testing Results.
   Pediatr Dermatol. 2026;43:605-608.
   PubMed     Abstract available
   
   
   
8. CREIGHTON R, Gupta S, Langille C, Sutherland A, et al
   Diagnosis and Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Pediatric Patients: A Systematic Review of Clinical Guidelines and Consensus Statements.
   Pediatr Dermatol. 2026;43:579-589.
   PubMed     Abstract available
   
   
   
9. LOPES ALMEIDA GOMES L, Mitchell D, Shah NJ, Greenfield M, et al
   Mycoplasma Rash With Eosinophilia and Systemic Symptoms: A Report of Two Cases.
   Pediatr Dermatol. 2026;43:729-733.
   PubMed     Abstract available
   
   
   
10. LIAO A, Shawa H, Compton L, Siegel L, et al
    Acute Generalized Exanthematous Pustulosis Mimicking Toxic Shock Syndrome in a Pediatric Patient.
    Pediatr Dermatol. 2026;43:711-714.
    PubMed     Abstract available
    
    
    April 2026
11. TE B, Kalia S, Gregory A, Rehmus W, et al
    Improving Primary Care of Pediatric Atopic Dermatitis: An Analysis of Referrals and Educational Need.
    Pediatr Dermatol. 2026 Apr 20. doi: 10.1111/pde.70216.
    PubMed     Abstract available
    
    
    March 2026
12. SEKI S, Kinoshita M, Takahata N, Horimukai K, et al
    Utility of Blood Biomarkers for Assessing Atopic Dermatitis Severity in Infants Aged < 2 Years.
    Pediatr Dermatol. 2026 Mar 29. doi: 10.1111/pde.70206.
    PubMed     Abstract available
    
    
    
13. CHOPRA P, Thapar M, Peoples K, Olson KE, et al
    A Survey-Based Study to Assess Caregiver Understanding of the Link Between Atopic Dermatitis and Food Allergy.
    Pediatr Dermatol. 2026 Mar 16. doi: 10.1111/pde.70161.
    PubMed     Abstract available
    
    
    
14. SHEA M, Haag C, Latour E, Simpson EL, et al
    Initial Management of Infantile Atopic Dermatitis in Primary Care Settings and Predictors of Topical Steroid Potency Escalation.
    Pediatr Dermatol. 2026 Mar 9. doi: 10.1111/pde.70170.
    PubMed     Abstract available
    
    
    
15. EICHENFIELD LF, Gonzalez ME, Boguniewicz M, Funk T, et al
    Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE).
    Pediatr Dermatol. 2026 Mar 8. doi: 10.1111/pde.70177.
    PubMed     Abstract available
    
    
    
16. MEARA EM, Antaya RJ
    Resolution of Refractory Cholinergic Urticaria in a Child Treated With Dupilumab.
    Pediatr Dermatol. 2026;43:479-480.
    PubMed     Abstract available
    
    
    February 2026
17. PATEL S, Shah RM, Lio PA, Hamm B, et al
    Inpatient Psychiatric Burden in Adolescents With Atopic Dermatitis.
    Pediatr Dermatol. 2026 Feb 22. doi: 10.1111/pde.70165.
    PubMed     Abstract available
    
    
    
18. KISZLUK A, Lio P
    The State of Prevention of Atopic Dermatitis: An Updated Review.
    Pediatr Dermatol. 2026 Feb 22. doi: 10.1111/pde.70157.
    PubMed     Abstract available
    
    
    
19. BUI JK, Finan C, Smith-Fraser A, Habeshian K, et al
    The Effects of Walk-In Dermatology Appointments for Atopic Dermatitis and Hidradenitis Suppurativa Management.
    Pediatr Dermatol. 2026 Feb 17. doi: 10.1111/pde.70155.
    PubMed     Abstract available
    
    
    January 2026
20. RIDD MJ, Brown SJ, Beattie P, Feeney M, et al
    Reply to Comment on 'Food Allergy Test-Guided Dietary Advice for Children With Atopic Dermatitis: A Consensus Study'.
    Pediatr Dermatol. 2026 Jan 15. doi: 10.1111/pde.16026.
    PubMed    
    
    
    
21. GUPTA A
    Comment on "Food Allergy Test-Guided Dietary Advice for Children With Atopic Dermatitis: A Consensus Study".
    Pediatr Dermatol. 2026 Jan 15. doi: 10.1111/pde.16010.
    PubMed    
    
    
    
22. LARRALDE M, Almassio A, Ferrari B, Angles V, et al
    Real-World Experience of Dupilumab in Children and Adolescents With Atopic Dermatitis in Argentina.
    Pediatr Dermatol. 2026;43:88-90.
    PubMed     Abstract available
    
    
    November 2025
23. LOUKA M, Colmenero I, Torrelo A
    A Child With Recurrent Bullous Lesions and Allergic Predisposition.
    Pediatr Dermatol. 2025 Nov 21. doi: 10.1111/pde.70109.
    PubMed    
    
    
    
24. LOISELLE AR, Johnson JK, Smith Begolka W
    Perceived Readiness and Barriers to Self-Management in Pediatric Atopic Dermatitis Patients and Parents.
    Pediatr Dermatol. 2025 Nov 18. doi: 10.1111/pde.70117.
    PubMed     Abstract available
    
    
    
25. 
    inverted question markQue es la dermatitis atopica?
    Pediatr Dermatol. 2025;42:E1-E2.
    PubMed    
    
    
    
26. 
    What is atopic dermatitis?
    Pediatr Dermatol. 2025;42:1270-1271.
    PubMed     Abstract available
    
    
    October 2025
27. TRIPATHY K, Brown-Soler I, Eisenstein A
    Food Insecurity and Its Effects on Individuals With Food Allergies and Atopic Dermatitis: A Comprehensive Review.
    Pediatr Dermatol. 2025 Oct 18. doi: 10.1111/pde.70083.
    PubMed     Abstract available
    
    
    
28. SAHIN MK, Erbay MF, Bologur H, Caliskan N, et al
    Triamcinolone and Dexamethasone Hypersensitivity: A Pediatric Case Report.
    Pediatr Dermatol. 2025 Oct 6. doi: 10.1111/pde.70055.
    PubMed     Abstract available
    
    
    September 2025
29. LEE S, Kim EJ, LeBovidge J, Aigbekaen I, et al
    Investigating the Use of Melatonin in Children With Atopic Dermatitis: A Cross-Sectional Study.
    Pediatr Dermatol. 2025 Sep 9. doi: 10.1111/pde.70041.
    PubMed     Abstract available
    
    
    
30. CHAN CJ, Visscher MO
    Prevention of Atopic Dermatitis in High-Risk Infants: A Review of the Role of Lipid-Based Barrier Repair Therapy.
    Pediatr Dermatol. 2025 Sep 4. doi: 10.1111/pde.70010.
    PubMed     Abstract available
    
    
    
31. BRUESS GES, Barry KK, Olsen GM, Foschi CM, et al
    Evaluating Outcomes of Live-Attenuated Vaccine Administration in Pediatric Patients on Dupilumab for Atopic Dermatitis.
    Pediatr Dermatol. 2025 Sep 2. doi: 10.1111/pde.70033.
    PubMed     Abstract available
    
    
    
32. MOHANDESI NA, Mittal S, Orandi AB, Smith WM, et al
    Expanding the Cutaneous Presentation of Blau Syndrome, Response to Treatment, and Correlation With Genetics.
    Pediatr Dermatol. 2025;42:956-960.
    PubMed     Abstract available
    
    
    
33. YILMAZ SY, Celik IK, Alkan G, Harmankaya I, et al
    Acute Generalized Exanthematous Pustulosis Associated With Human Parvovirus B19 in an 11-Year-Old Girl.
    Pediatr Dermatol. 2025;42:1095-1096.
    PubMed     Abstract available
    
    
    
34. ABOUDOURIB M, Karim O, El Alaoui A, Maoulainine FMR, et al
    Phototherapy-Induced Yellow Urticaria in a Neonate.
    Pediatr Dermatol. 2025;42:1090-1091.
    PubMed     Abstract available
    
    
    July 2025
35. LANEHART MH, Hayes B, Zinn Z, Skoner DP, et al
    Dupilumab Treatment for Atopic Dermatitis Is Associated With Decreased Risk of Otitis Media and Related Surgical Procedures: A Retrospective Cohort Study.
    Pediatr Dermatol. 2025 Jul 16. doi: 10.1111/pde.16008.
    PubMed     Abstract available
    
    
    
36. WANG OJE, Jacob M, Crawford RI, Lam JM, et al
    Blau Syndrome (Juvenile Systemic Granulomatosis): State-Of-The-Art Review.
    Pediatr Dermatol. 2025;42:728-734.
    PubMed     Abstract available
    
    
    
37. CHIONG T, Koh MJA
    Radiotherapy-Induced Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis in an Adolescent Girl With Diffuse Glioma of the Pons.
    Pediatr Dermatol. 2025;42:877-879.
    PubMed     Abstract available
    
    
    May 2025
38. CHANG HR, Su HJ, Kartawira K, Grossberg A, et al
    Feasibility and Acceptability of Patient-Reported Outcomes Collection in Routine Pediatric Atopic Dermatitis Care.
    Pediatr Dermatol. 2025 May 31. doi: 10.1111/pde.15972.
    PubMed     Abstract available
    
    
    
39. LIN Z, Piao S, Wang A
    Comparative Evaluation of ChatGPT and ChatGLM Performance in Response to Common Queries on Pediatric Atopic Dermatitis.
    Pediatr Dermatol. 2025 May 28. doi: 10.1111/pde.15988.
    PubMed     Abstract available
    
    
    
40. LI Z, Mai X, Liao Y, Yang H, et al
    Exploring Treatment Adherence in Children Aged 0-6 With Atopic Dermatitis: A Pilot Cross-Sectional Study in China.
    Pediatr Dermatol. 2025 May 28. doi: 10.1111/pde.15968.
    PubMed     Abstract available
    
    
    
41. YUAN R, Zhang X, Liu Y, Liu H, et al
    Erythematous Plaques and Nodules in a Child.
    Pediatr Dermatol. 2025;42:643-645.
    PubMed     Abstract available
    
    
    
42. BALAN BK, Ersoy-Evans S, Isiyel E, Alehan D, et al
    SAM Syndrome Presenting With Pulmonary Stenosis: A Case Report and Literature Review.
    Pediatr Dermatol. 2025;42:584-590.
    PubMed     Abstract available
    
    
    April 2025
43. JOHNSON J, Matiz C, Admani S
    Prevalence of Common Contact Allergens in Topical Diaper Preparations for Infants.
    Pediatr Dermatol. 2025 Apr 22. doi: 10.1111/pde.15945.
    PubMed     Abstract available
    
    
    
44. EICHENFIELD LF, Shi VY, Yu J, Pierce EJ, et al
    Patient-Reported Impact of Atopic Dermatitis on Pediatric and Adolescent Patients With Moderate-To-Severe Disease: Results of a Real-World, Cross-Sectional Survey.
    Pediatr Dermatol. 2025 Apr 20. doi: 10.1111/pde.15940.
    PubMed     Abstract available
    
    
    
45. GOTTLIEB S, Madkins K, Lio P
    An Updated Scoping Review of Disparities in Pediatric Atopic Dermatitis.
    Pediatr Dermatol. 2025 Apr 1. doi: 10.1111/pde.15914.
    PubMed     Abstract available
    
    
    March 2025
46. YUN S, Jenkins BA, Scollan ME, Defelice AR, et al
    Pemphigus Vulgaris With Esophageal Involvement in an Atopic Child Successfully Treated With Dupilumab.
    Pediatr Dermatol. 2025;42:371-375.
    PubMed     Abstract available
    
    
    
47. PALLER AS, Ramien M, Cork MJ, Simpson EL, et al
    Low Infection Rates With Long-Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open-Label Extension Study.
    Pediatr Dermatol. 2025;42:251-258.
    PubMed     Abstract available
    
    
    
48. JAROS SC, Morrell DS, Nieman EL
    Agminated Eruptive Melanocytic Nevi and Nail Changes Following Toxic Epidermal Necrolysis in a Pediatric Patient: A Case Report and Systematic Review of the Literature.
    Pediatr Dermatol. 2025;42:364-370.
    PubMed     Abstract available
    
    
    February 2025
49. BECKER SL, Kenny L, Small A
    Basiliximab for IL-2-Associated Inflammatory Disorder With Atopic Dermatitis.
    Pediatr Dermatol. 2025 Feb 25. doi: 10.1111/pde.15913.
    PubMed     Abstract available
    
    
    
50. EICHENFIELD LF, Serrao R, Prajapati VH, Browning JC, et al
    Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.
    Pediatr Dermatol. 2025 Feb 20. doi: 10.1111/pde.15840.
    PubMed     Abstract available
    
    
    
51. CHAU CA, Loiselle AR, Johnson JK, Begolka WS, et al
    Caregiver-Reported Motivation and Access to Mental Health Services for Pediatric Atopic Dermatitis Patients: A Cross-Sectional Study.
    Pediatr Dermatol. 2025 Feb 9. doi: 10.1111/pde.15880.
    PubMed     Abstract available
    
    
    January 2025
52. BAFFA ME, Bianchi L, Venturini E, Pimpinelli N, et al
    A Pediatric Case of Severe Atopic Dermatitis on Dupilumab Treatment and Pulmonary Tuberculosis.
    Pediatr Dermatol. 2025 Jan 29. doi: 10.1111/pde.15862.
    PubMed    
    
    
    
53. KATSIAUNIS A, Petrillo M, Robinson SN
    Labial Melanotic Macules in Two Pediatric Patients of Chinese Descent With Atopic Dermatitis.
    Pediatr Dermatol. 2025 Jan 29. doi: 10.1111/pde.15879.
    PubMed     Abstract available
    
    
    
54. BUI JK, Baker M, Habeshian K
    Two for One: Tuberculid and Leukocytoclastic Vasculitis in an Adolescent.
    Pediatr Dermatol. 2025;42:154-157.
    PubMed     Abstract available
    
    
    
55. JORGAQI E, Ezenne K, Brown M, Zhou AE, et al
    Congenital Erythropoietic Porphyria: A Case of Hepatic Failure and Angioedema Following Ferrous Sulfate Supplementation.
    Pediatr Dermatol. 2025;42:166-169.
    PubMed     Abstract available
    
    
    
56. CHIU LW, Dibas BI, Walker PD, Smidt AC, et al
    Immunoglobulin A vasculitis with periorbital edema and severe renal involvement: A case report.
    Pediatr Dermatol. 2025;42:129-132.
    PubMed     Abstract available
    
    
    December 2024
57. YOUN CG, Kim JY, Chen JK, Siegel DH, et al
    Decreased Sleep Duration and Increased Use of Medication to Aid Sleep Among Parents of Children With Atopic Dermatitis: A Cross-Sectional Study of the National Health Interview Survey, 2013-2018.
    Pediatr Dermatol. 2024 Dec 12. doi: 10.1111/pde.15839.
    PubMed     Abstract available
    
    
    
58. WONG JJ, Margolis DJ
    Association Between Food Allergy Status and Atopic Dermatitis Control and Persistence: A Longitudinal Analysis of the Pediatric Eczema Elective Registry.
    Pediatr Dermatol. 2024 Dec 10. doi: 10.1111/pde.15845.
    PubMed     Abstract available
    
    
    November 2024
59. MUHAIDAT J, Fawwaz AM, Al-Qarqaz F, Alshiyab D, et al
    Moisturizer Use in Children With Atopic Dermatitis: Real-Life Practice, Beliefs, and Challenges Among a Cohort of Jordanian Patients.
    Pediatr Dermatol. 2024 Nov 25. doi: 10.1111/pde.15821.
    PubMed     Abstract available
    
    
    
60. YAP AXY, Tan D, Koh MJ, Yang LY, et al
    Dupilumab-Associated Ocular Surface Disease in Pediatric Atopic Dermatitis: A Single-Center Asian Experience.
    Pediatr Dermatol. 2024 Nov 20. doi: 10.1111/pde.15814.
    PubMed     Abstract available
    
    
    
61. GARSIDE L, Boyle R, Meyer R, Skypala I, et al
    Food Allergy Test-Guided Dietary Advice for Children With Atopic Dermatitis: A Consensus Study.
    Pediatr Dermatol. 2024 Nov 11. doi: 10.1111/pde.15807.
    PubMed     Abstract available
    
    
    
62. JUNGWATTANAVANIT P, Wananukul S, Tempark T, Chantawarangul K, et al
    Efficacy of a Video Education Program Regarding Basic Skin Care in Pediatric Atopic Dermatitis: A Randomized Controlled Trial.
    Pediatr Dermatol. 2024 Nov 4. doi: 10.1111/pde.15798.
    PubMed     Abstract available
    
    
    
63. AHUJA K, Lio P
    Readability of patient materials on atopic dermatitis: The possible role of artificial intelligence.
    Pediatr Dermatol. 2024;41:1251-1252.
    PubMed    
    
    
    
64. BROWN AB, Park AJ, Agim NG, Gordon KA, et al
    Characterizing drug-induced epidermal necrolysis in a pediatric cohort.
    Pediatr Dermatol. 2024;41:1127-1130.
    PubMed     Abstract available
    
    
    
65. MANI S, Morris L, Bayliss SJ
    Recurrent erythema multiforme-like reaction secondary to recurrent poison ivy exposure.
    Pediatr Dermatol. 2024;41:1156-1158.
    PubMed     Abstract available
    
    
    October 2024
66. DICK JK, Boull C, Pozos TC, Maguiness SM, et al
    Improvement in Atopic Dermatitis and Recurrent Infection With Dupilumab in Children With Distinct Genetic Types of Hyper-IgE Syndrome: A Case Series and Literature Review.
    Pediatr Dermatol. 2024 Oct 18. doi: 10.1111/pde.15780.
    PubMed     Abstract available
    
    
    
67. DAGENET CB, Gawey L, Davoudi S, Ma E, et al
    Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review.
    Pediatr Dermatol. 2024 Oct 4. doi: 10.1111/pde.15771.
    PubMed     Abstract available
    
    
    
68. FONG WCG, Kaung HHW, Lopes R, Kanji A, et al
    A Case Series of Refractory Pediatric Atopic Dermatitis Effectively Treated With Dupilumab in Combination With Abrocitinib.
    Pediatr Dermatol. 2024 Oct 3. doi: 10.1111/pde.15761.
    PubMed     Abstract available
    
    
    September 2024
69. BANBURY S, Milgraum DM, Lewis DJ, Queenan M, et al
    Post-streptococcal small-vessel vasculitis in a 16-month-old with associated intussusception and hypertension: Henoch Schonlein purpura?
    Pediatr Dermatol. 2024;41:929-931.
    PubMed     Abstract available
    
    
    July 2024
70. HARTZELL CJ, Szabova A, Collins AB, Morel AN, et al
    Efficacy of aprepitant for refractory pruritus in patients with epidermolysis bullosa and atopic dermatitis: A retrospective study.
    Pediatr Dermatol. 2024 Jul 25. doi: 10.1111/pde.15704.
    PubMed     Abstract available
    
    
    
71. WIESER JK, Larson BI, Shah SD
    From flare to care: Dermatologists' impact on pediatric atopic dermatitis hospital admissions.
    Pediatr Dermatol. 2024 Jul 25. doi: 10.1111/pde.15694.
    PubMed     Abstract available
    
    
    
72. METKO D, Mehta S, Sibbald C
    Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review.
    Pediatr Dermatol. 2024 Jul 4. doi: 10.1111/pde.15691.
    PubMed     Abstract available
    
    
    
73. KEELING E, Cotter C, O'Mahony S, Andrawis M, et al
    Bier anemic spots, cyanosis, and urticaria-like eruption (BASCULE) syndrome in a 15-year-old male, responsive to high-dose fexofenadine.
    Pediatr Dermatol. 2024;41:731-732.
    PubMed     Abstract available
    
    
    
74. FANOUS N, Clarke E, Levy ML
    Posterior reversible encephalopathy syndrome in the setting of IgA vasculitis.
    Pediatr Dermatol. 2024;41:728-730.
    PubMed     Abstract available
    
    
    May 2024
75. GUPTA S, Ramam M, Sharma VK, Sethuraman G, et al
    Reply to "Correspondence on Evaluation of a paraffin based moisturizer compared to a ceramide based moisturizer in children with atopic dermatitis: A double-blind, randomized controlled trial".
    Pediatr Dermatol. 2024;41:565.
    PubMed    
    
    
    
76. HIRT PA, Gonzalez AM, Acosta AS, Price A, et al
    Cutaneous Mycobacterium avium-intracellulare infection masquerading as sarcoidosis.
    Pediatr Dermatol. 2024;41:497-500.
    PubMed     Abstract available
    
    
    
77. LOCKARD T, Mullen SA, Lee EB, Niebur H, et al
    Dupilumab-induced psoriasiform dermatitis in two pediatric cardiac transplant patients.
    Pediatr Dermatol. 2024;41:508-511.
    PubMed     Abstract available
    
    
    April 2024
78. BRUMLEY C, Banks T, Arora P, Ophaug S, et al
    Are "clean" products safe for children? An analysis of contact allergens in "clean" children's products from a popular retailer.
    Pediatr Dermatol. 2024 Apr 27. doi: 10.1111/pde.15633.
    PubMed     Abstract available
    
    
    March 2024
79. HERNANDEZ LE, Schachner LA
    Comment on "Evaluation of a paraffin-based moisturizer in children with atopic dermatitis: A double-blind, randomized controlled trial".
    Pediatr Dermatol. 2024;41:374-375.
    PubMed    
    
    
    
80. KING A, Pope E
    Dermatitis versus nonaccidental trauma: A systematic review of initial pediatric misdiagnoses.
    Pediatr Dermatol. 2024;41:215-220.
    PubMed     Abstract available
    
    
    
81. REYES-SOTO MA, Perales-Gonzalez A, Rivera-Alonso IA, Leon ALY, et al
    Cold urticaria as a complication of cryotherapy in the treatment of viral warts.
    Pediatr Dermatol. 2024;41:372-373.
    PubMed     Abstract available
    
    
    
82. KIM EJ, Zhang Z, Hlobik M, Ho T, et al
    Urticaria in infants: A single-institution retrospective study.
    Pediatr Dermatol. 2024;41:260-262.
    PubMed     Abstract available
    
    
    
83. ESFANDIARI N, Vandyke S, Porter HJ, Shea K, et al
    A case of mevalonate kinase deficiency, neonatal Sweet syndrome, and inflammatory bowel disease.
    Pediatr Dermatol. 2024;41:298-301.
    PubMed     Abstract available
    
    
    February 2024
84. PALLER AS, Green LJ, Silverberg N, Stripling S, et al
    Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis.
    Pediatr Dermatol. 2024 Feb 27. doi: 10.1111/pde.15575.
    PubMed     Abstract available
    
    
    
85. NOVEIR SD, Galamgam J, Cheng CE
    Prevalence of potential contact allergens in best-selling baby cleansers.
    Pediatr Dermatol. 2024 Feb 27. doi: 10.1111/pde.15570.
    PubMed     Abstract available
    
    
    September 2023
86. OHYA Y, Saeki H, Nawata H, Arima K, et al
    The disease burden of pediatric patients with atopic dermatitis in Japan.
    Pediatr Dermatol. 2023;40:851-856.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum